NMM
UTHR icon

Naples Money Management’s United Therapeutics UTHR Stock Holding History

Naples Money Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.58K Hold
10
– – ﹤0.01% 255
2024
Q2 		$3.19K Buy
10
+4
+67% +$1.06K ﹤0.01% 272
2024
Q1 		$1.38K Hold
6
– – ﹤0.01% 339
2023
Q4 		$1.32K Buy
+6
New +$1.38K ﹤0.01% 358

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Naples Money Management's UTHR Position: Q3 2024 in Review

Naples Money Management held its United Therapeutics (UTHR) position steady in Q3 2024 at 10 shares worth $3.58K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Naples Money Management first reported a position in UTHR in Q4 2023 and has held it in 4 quarters since. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Naples Money Management held 10 shares of United Therapeutics worth $3.58K as of Q3 2024.
  • Naples Money Management left its United Therapeutics share count unchanged in Q3 2024.
  • United Therapeutics made up ﹤0.01% of Naples Money Management's portfolio in Q3 2024, its #255 holding.
  • Naples Money Management first reported a position in United Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.